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Abstract
Background: CCR7-mediated signalling is important for dendritic cell maturation and homing to the lymph nodes. We have
previously demonstrated that Jak3 participates in the signalling pathway of CCR7 in T lymphocytes.
Methodology and Principal Findings: Here, we used Jak3
2/2 mice to analyze the role of Jak3 in CCR7-mediated dendritic
cells migration and function. First, we found no differences in the generation of DCs from Jak3
2/2 bone marrow
progenitors, when compared to wild type cells. However, phenotypic analysis of the bone marrow derived DCs obtained
from Jak3
2/2 mice showed reduced expression of co-stimulatory molecules compared to wild type (Jak3
+/+). In addition,
when we analyzed the migration of Jak3
2/2 and Jak3
+/+ mature DCs in response to CCL19 and CCL21 chemokines, we
found that the absence of Jak3 results in impaired chemotactic responses both in vitro and in vivo. Moreover, lymphocyte
proliferation and contact hypersensitivity experiments showed that DC-mediated T lymphocyte activation is reduced in the
absence of Jak3.
Conclusion/Significance: Altogether, our data provide strong evidence that Jak3 is important for DC maturation, migration
and function, through a CCR7-mediated signalling pathway.
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Introduction
Dendritic cells are professional antigen presenting cells with a
unique ability to activate naive T cells Bone marrow Dendritic
cells (BMDCs) are found as precursors in the blood, from where
they traffic to different tissues and capture antigen very efficiently
[1]. These immature dendritic cells (iDCs) do not exhibit
considerable APC’s activity; only after antigen contact, the
maturation process takes place. These iDC recognize microbial
structures such as Pathogen-Associated Molecular Patterns
(PAMPs) and Damage-Associated Molecular Patterns (DAMP)
using Pattern Recognition Receptors (PRRs). During this process,
an increase of MHC-II molecules as well as co-stimulatory
molecules, such as CD80, CD86 and CD40, allows DCs to
become potent APCs. Additionally, a change in their chemokine
receptor expression is important for migration from peripheral
tissues, via afferent lymphatics, to the T cell areas of regional
lymph nodes (LN) [2,3].
Chemokines are small chemotactic cytokines (8–10 kDa) that
regulate migration and localization of leukocytes in different
tissues. Different cell types, including stromal, epithelial and
endothelial cells, secrete chemokines, both under inflammatory
and homeostatic conditions. Chemokines bind to 7-transmem-
brane domain G-protein coupled receptors (7TM-GPCR). Among
these receptors, CCR7 is highly expressed on mature DCs, and its
ligands, CCL21 and CCL19 are expressed in LN and spleen.
Moreover, CCL21 is expressed in high endothelium venules
(HEV) and in the lymphatic endothelium of multiple tissues[4]. In
this context, DCs from CCR7 deficient mice fail to form dermal
‘‘cords’’ at the dermal lymphatic vessels, and show impaired
migration into LN. Consequently, these incorrectly localized DCs
are incapable to promote appropriate immune responses [5].
Furthermore, CCL19 and CCL21 have shown to be potent
stimulators of DC maturation [6]. Additionally, CCL19 optimizes
the DC-T cell interaction and increases the frequency of T cell
responses to rare cognate antigen [7]. In this context, DCs from
mice deficient in both CCL19 and CCL21 chemokines (plt/plt),
fail to accumulate in the T cell zones [8] and display defects in DC
maturation, as it was demonstrated by a reduction in the
expression of costimulatory molecules [6].
Our laboratory and others have demonstrated that the
Jak/Stat pathway plays a role in chemokine-mediated signalling
[9,10,11,12]. In particular, we have demonstrated that Jak3 is
involved in signalling through CCR9 and CXCR4 in murine BM
cells and thymocytes [13]. Furthermore, in the absence of Jak3
mature T lymphocytes have impaired CCL19/CCL21-mediated
homing to peripheral lymph nodes, mainly due to deficient CCR7
mediated signalling [14].
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7066In this report, we further evaluated the role of Jak3 in DC
maturation and migration using a Jak3 deficient (Jak3
2/2) mouse
model. We found that BMDCs derived from these mice show
impaired migration towards CCL19 and CCL21. In addition, in
vitro maturation of BMDCs induced by LPS was significantly
affected and Jak3
2/2 BMDCs showed reduced ability to stimulate
allogeneic T cell proliferation responses. Moreover, contact
hypersensitivity assays (CHS) performed in Jak3
2/2 mice showed
a significant reduction in ear thickness, compared to wild type
mice, which correlated with decreased Langerhans cells (LC)
recruitment at the induction zone after challenge and a reduced
inflammatory response. Our data suggests that Jak3 may play an
important role in regulating DC functions in vivo, both in
homeostasis and under inflammatory conditions.
Results
Dendritic cell maturation is impaired in the absence of
Jak 3
To test whether the absence of Jak3 affects the in vivo
generation of DCs, phenotypical FACS analysis of cells isolated
from Jak3
2/2 spleen was performed using anti-CD11c, anti-
MHC Class II, and anti-CD80 or anti-CD86 antibodies. As
shown in Figure 1A, no differences were observed in the
percentage of DCs present in Jak3
2/2 compared to Jak3
+/+
mice. In addition, analysis of the maturation markers showed
that DCs from Jak3
2/2 mice expressed higher levels of CD80
(p=0.047), consistent with a previous report [15],
although CD86 levels were not significantly different in the
Figure 1. Normal Dendritic cell development in Jak3
2/2 mice. FACS analysis from cells isolated from Jak3
+/+ and Jak3
2/2 spleen were stained
with anti-CD11c, anti-MHCII, anti-CD80 and anti-CD86 antibodies. A) Histogram representing the percentage of cells expressing CD11c
+ MHCII
+. Data
represent mean values 6SEM (n=9). B) A representative dot plot analysis of the expression of CD11c
+ MHCII
+ in DC cells. C) Analysis of
maturation markers CD80 and CD86. A representative experiment is shown. CTL: isotype control. M1 indicates the region used to calculate the % of
positive cells for each costimulatory molecule.
doi:10.1371/journal.pone.0007066.g001
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2/2 mice compared to Jak3
+/+ mice (p=0.45) (Fig. 1B, and
supplementary Figure S1).
Next, to analyze the capacity of Jak3
2/2 mice to generate DCs
in vitro, BM cells were obtained and cultured in the presence of
GMCSF, as described in materials and methods, LPS was used to
induce DC maturation and expression of CD80, CD86 and MHC
Class II was analysed by FACS. Analysis of immature BMDCs
(iBMDCs) showed that Jak3
2/2 BM cells were capable to induce
the differentiation of CD11c
+ cells in vitro to the same extent as
Jak3
+/+ cells (data not shown). Unexpectedly, after LPS
stimulation, the percentage of CD11c
+ cells in culture was
significantly higher in BMDCs derived from Jak3
2/2 mice,
compared to wild type mice (Fig. 2A). However, FACS analysis
showed that after stimulation with LPS, Jak3
2/2 BMDCs had
impaired up-regulation of maturation markers, MHC Class II,
CD80 and CD86 (Fig. 2B and Fig. 2C). These results suggested
that in the absence of Jak3, their maturation process might be
compromised.
Impaired chemotaxis of Jak3
2/2 DCs towards CCL19 and
CCL21 chemokines
CCR7 is important for DCs migration both under inflammatory
and homeostatic conditions [5]. Both CCR7 ligands, CCL19 and
CCL21, are expressed in lymphatic organs, although only CCL21 is
expressed in lymphatic vessels. Arrival of DCs to LNs is guided by the
interaction with these chemokines. Earlier, we have reported that
Jak3 was involved in CCR7-mediated T lymphocyte homing to
peripheral LNs [14]. To further study the role of Jak3 in CCR7-
dependent DC migration, we analyzed the migration capacity of
mature BMDCs (mBMDCs) derived from Jak3
2/2 and Jak3
+/+ mice
using in vitro chemotaxis assays. BMDCs from Jak3
+/+ showed
efficient migration to CCL19 and CCL21 at concentrations ranging
between 10 and 500 ng/ml, before (iBMDCs, data not shown) and
after (mBMDCs) addition of LPS. In contrast, mBMDCs from
Jak3
2/2 mice showed negligible chemotactic responses to both
chemokines (Fig. 3). To exclude the possibility that impaired
migration was due to deficiencies in CCR7 expression on Jak3
2/2
Figure 2. Impaired maturation of Jak3
2/2 Bone Marrow derived Dendritic Cells. DCs were derived from Jak3
+/+ and Jak3
2/2 bone marrow
progenitors and stimulated with LPS (1 mg/ml) to obtain mature BMDCs (mBMDCs) as described in Methods. mBMDCs were stained using anti-CD11c,
anti-MHC-II, anti-CD80 and anti-CD86 antibodies. A) Histograms representing % of CD11c cells in BMDCs from Jak3
+/+ (filled) and Jak3
2/2 (empty)
(*p#0.05). B) Analysis of the expression of costimulatory molecules in BMDCs from Jak3
+/+ and Jak3
2/2. Filled histogram represent mBMDCs, grey
histogram represent iBMDCs and empty histogram, control antibodies. On the right panel, the Table summarizes the data obtained in this
representative experiment, indicating the % of CD11c
+ and the MFI values of iBMDC and mBMDC from Jak 3
+/+ and Jak 3
2/2 mice,
respectively. C) Mean fluorescence intensity increment of the expression of maturation markers after LPS stimulation. This value was calculated as
the increment in MFI from mBMDCs, relative to the value from iBMDCs as described [41]. Results are shown from a representative experiment (n=14;
*p#0.05).
doi:10.1371/journal.pone.0007066.g002
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were found between Jak3
+/+ and Jak3
2/2 BMDCs; approximately
80% of CD11c
+ cells were CCR7
+ after LPS stimulation in both
Jak3
+/+ and Jak3
2/2 mice (Fig. 4A). The mean fluorescence intensity
of CCR7
+ cells was not significantly different in either iBMDC (not
shown) or mBMDC from Jak3
+/+ and Jak3
2/2 mice (Fig. 4B). This
result indicated that impaired DC migration was rather due to
C C R 7d e f i c i e n ts i g n a l l i n gt h a ne x p r e s s i o ni nt h ea b s e n c eo fJ a k 3 .
Figure 3. Analysis of chemotaxis of Jak3
2/2 DCs towards CCL19 and CCL21 ligands. An in vitro chemotaxis assay was performed using
mBMDCs (24 h after LPS stimulation) from Jak3
+/+ and Jak3
2/2 mice. 2610
6 cells/ml were resuspended in the chemotaxis buffer with Ca
++ and Mg
++,
and allowed to migrate towards different concentrations of CCL19 and 21 chemokines. Analysis of migrating cells was performed as described in
methods. In the Y-axis is represented the fluorescence intensity (total counts) corresponding to migrating cells. This figure shows one representative
of four independent experiments (n=12; *p#0.05).
doi:10.1371/journal.pone.0007066.g003
Figure 4. Jak3
2/2 DCs express normal levels of CCR7 on their surface. Immature and mature BMDCs from Jak3
+/+ and Jak3
2/2 mice were
labelled with a CCL19-Fc fusion protein followed by anti-hIgG-FITC and analyzed by flow cytometry to determine CCR7 levels on the CD11c
+gated
subpopulations. A) Analysis of expression of CCR7 in iBMDC and mBMDCs from Jak3
+/+ (thick line) and Jak3
2/2 (grey shadow). Thin line represents
the secondary antibody control (CTL). B) Analysis of the iBMDC and mBMDC mean fluorescence of CCR7
+ and % of mBMDC CCR7
+ cells of Jak3
+/+ and
Jak3
2/2 mice. Data represent the mean of three different experiments (n=6; *p,0.05).
doi:10.1371/journal.pone.0007066.g004
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(Langerhans cells) from epidermis to dermis, but is
required for seeding regional lymph nodes
Langerhans cells (LC) are a type of DCs present in the skin,
whose function is to capture antigen and migrate to lymph nodes,
via afferent lymphatics, where they stimulate naive T cells. The
first step for LC mobilization is their migration from epidermis to
dermis; this process is not dependent on CCR7, as it was
demonstrated by means of skin explants cultures [5]. Similarly, we
analyzed the role of Jak3 in regulating LC migration using a
mouse ear skin model. In this system, ear skin was floated directly
on culture medium (dermis down). After 24 h and 48 h, epidermis
and dermis were separated, to identify LCs, epidermis was stained
with an anti-Langerin antibody. As shown in Fig. 5A, reduced
numbers of LCs were present in the skin from Jak3
2/2 mice after
24–48 h of culture, compared to Jak3
+/+ mice. To exclude the
possibility that this reduction was the result of a decrease in
Langerin expression, we also analysed the epidermis by using anti-
MHC Class II staining (data not shown). These observations may
indicate that, in the absence of Jak3, LCs exit the epidermal
compartment at a faster rate compared with Jak3
+/+ mice (Fig. 5B).
Once DCs enter the dermis, they need to adhere, likely through
lymphatic formations known as dermal cords. We analysed this
process and investigated whether in the absence of Jak3,
chemokine receptor-mediated signalling had an effect on the
formation of these cords. Accordingly, after 48 h culture, the
presence of structures resembling dermal cords was evident in skin
explants from Jak3
+/+ mice. On the contrary, Jak3
2/2 explants
showed no evidence of these structures, similarly to that reported
in the CCR7 mice
2/2 (Fig. 5C).
To further verify that Jak3 deficiency may also affect in vivo
migration of DCs, Jak3
2/2 mice were crossed to Green
Fluorescent Protein (GFP)-Jak3
+/+ mice to obtain GFP
+-Jak3
2/2
mice. BMDCs were derived from both GFP
+-Jak3
+/+ and GFP
+-
Jak3
2/2 mice and allowed to maturate in vitro, as before. These
mBMDCs were injected into the right footpad of Jak3
+/+ mice.
The left footpad was injected with PBS and used as control.
Popliteal LN were obtained at different times and the percentages
of GFP
+ cells were analyzed by flow cytometry. GFP
+ Jak3
+/+
Figure 5. Normal LC migration from the epidermis but abnormal localization around dermal lymphatics in Jak3
2/2 mice. A) Ears from
Jak3
+/+ and Jak3
2/2 mice were separated into dorso-ventral halves and the whole skin was cultured in RPMI 10% FBS. At different times, pieces were
removed and the dermis was separated from the epidermis to get epidermal sheets, as described in Materials and Methods. They were fixed in
acetone and stained with anti-Langerin followed of an anti rat IgG-FITC antibody. Figure represents 406magnification. B) The number of LC in the
skin after the culture was quantified. Data represent mean values 6 SEM (n=6; *p#0.05). C) Whole cultured skin was frozen and cryostat sections
were obtained to expose the epidermis and dermis. Sections were stained overnight with anti-Langerin followed by anti-rat IgG FITC. DCs in the
Jak3
+/+ mice are located around lymphatic vessels forming dermal cords; these are not visible in Jak3
2/2 mice.
doi:10.1371/journal.pone.0007066.g005
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with a peak between 36 h and 48 h. In contrast, the number of
GFP
+ -Jak3
2/2 DCs emigrants was reduced, compared to Jak
3
+/+ DCs (Fig. 6A and 6B), remaining low even at 72 h after the
transfer (data not shown). This evidence demonstrates that Jak3
has a role in regulating migration of mBMDCs to the LN. In this
context, it has been reported that DCs from CCR7
2/2 mice fail to
migrate into the lymph nodes [3,5]. This data supports the
hypothesis that Jak3 is necessary for both in vitro and in vivo CCR7-
dependent migration of DCs.
Reduced proliferative T cell responses induced by Jak3
2/2
DCs
One of the hallmarks of DC’s functions is T lymphocyte
activation. Since Jak3
2/2 mBMDC showed reduced expression of
maturation markers after LPS stimulation, it was of interest to
know whether this function was affected. Using a MLR assay, T
lymphocytes were stimulated with DCs from both Jak3
+/+ and
Jak3
2/2 mice at different ratios. Our assays showed that DCs
from Jak3
2/2 mice were able to stimulate similar proliferative
responses of T lymphocytes at ratio of 1:1 to 1:4 (DC: TL). In
contrast, at a ratio of 1:20, BMDCs from Jak3
2/2 mice promoted
a weak proliferation of CD4 and CD8 T lymphocytes compared to
Jak3
+/+ (Figs. 7A and 7C).
Analysis of in vivo migration of DCs by a Contact
Hypersensitivity (CHS) assay
Next, based on the results obtained in the in vitro chemotaxis and
in vivo adoptive transfer assays, we decided to test whether Jak3 was
involved in LC migration during a CHS response. A CHS
response is a T-cell mediated skin inflammation reaction resulting
from exposure to haptens. DNFB was used as hapten to induce
CHS in both Jak3
+/+ and Jak3
2/2 mice. A 1% DNFB solution
was applied onto the left ear of each mouse. Five days later, the
right ear was challenged with the same solution. Ear skin was
obtained and initially stained by H & E (Fig. 8A); total cell number
was quantified at different time points. This analysis demonstrated
a statistically significant difference between Jak3
+/+ and Jak3
2/2
mice in the number of total cells recruited after 72 h of challenge
(Fig. 8B). At 6 and 72 h after challenge, ear thickness in both
Jak3
+/+ and Jak3
2/2 mice was also measured and compared with
ear thickness unchallenged. There was a considerable increase in
the size of the treated ear from Jak3
+/+ compared to Jak3
2/2 mice
at 72 h after challenge (Fig. 8C). This data demonstrate that
the absence of Jak3 results in a defect in cell recruitment
under inflammatory conditions. In fact, in vivo adoptive
transfer of mBMDCs showed that, in the absence of Jak3,
mBMDCs were greatly impaired in their homing to LNs (Fig. 6A).
Additionally, to identify LCs, epidermal sheets were stained with
anti-Langerin and Anti-MHC Class II antibodies (Fig. 9A). As
shown, 6 h after challenge, epidermal sheets from Jak3
+/+ mice
showed a decrease in the number of LC, which was even lower in
Jak3
2/2 mice. However, 72 h after challenge, the percentage of
Jak3
+/+ LCs was already recovered while it was very low in the
epidermal sheets from Jak3
2/2 mice (Fig. 9B), suggesting that
Jak3-mediated signalling is part of a complex mechanism
regulating migration of LCs (see scheme in supplementary
Figure S2).
Discussion
The Jak/Stat pathway has been shown to be an important
regulator of chemokine receptor signalling [16,17]. Specifically, it
was reported that different members of the Janus family of kinases
(Jak1, Jak2, Jak3 and Tyk2), become tyrosine phosphorylated upon
stimulation with various chemokines in different cell types
[reviewed in [18].
Our laboratory has previously shown that Jak3 is involved in
CCR9 and CXCR4 receptor signalling in bone marrow
Figure 6. Jak3
2/2 DCs showed impaired homing to the lymph nodes after adoptive transfer. Mature BMDCs were obtained from Jak3
+/+-
GFP and Jak3
2/2-GFP mice and injected into the footpad of Jak3
+/+ mice, as described in Methods. At different time points, popliteal LNs were
collected and the percent of GFP
+ cells were determined by FACS analysis. A) Representative dot plot of three individual experiments at 36 h after
transfer. B) Data represent the mean of three independent experiments 36 h after transfer (n=9, *p,0.05).
doi:10.1371/journal.pone.0007066.g006
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phosphorylation of Jak3 in peripheral lymphocytes in response
to CCL19 and CCL21 is important for T lymphocyte homing to
peripheral lymph nodes [14], which may partially explain the
absence of peripheral lymph nodes and Peyer’s patches in Jak3
2/2
mice.
In this report, we investigated the role of Jak3 in regulating DC
migration and function. We found that in the absence of Jak3,
mice were capable to generate DCs in vivo, since normal numbers
of CD11c
+ MHC Class II
+ cells were found in the spleen of these
mice. This is in contrast to a previous report showing decreased
numbers of splenic DCs in Jak3
2/2 mice [15]. In addition, when
we compared in vitro-generated DCs from bone marrow
progenitors (iBMDCs) no quantitative differences were observed
between Jak3
2/2 mice and Jak3
+/+ mice. Interestingly, in vitro
LPS-induced maturation of BMDCs led to significantly higher
numbers CD11c
+ cells in the absence of Jak3
2/2, which correlates
with the fact that Jak3 has been shown to act as a negative
regulator of DC survival [15]. However, we found that DCs
maturation after LPS stimulation is strongly affected in Jak3
2/2
BMDCs, since the increase of surface CD80, CD86 and MHC
Class II molecules was clearly impaired in Jak3
2/2 DCs compared
to Jak3
+/+ cells. This result contrasts with a previous report
showing that maturation of DCs is not affected in the absence of
Jak3. However, in this report the authors used Ftl3-L to
derive DC from bone marrow, and in addition they used
CD40 cross-linking instead of LPS, as maturation
stimulus. Finally this report only reported changes in
the expression levels of CD86 [15], while we have also
analyzed MHC Class II and CD80 expression.
There is growing evidence showing that chemokines and
chemokine receptors participate in the maturation process of
DCs. CXCL12/CXCR4 has been involved in promoting
maturation and survival of BMDCs. Their involvement was
demonstrated by using CXCR4 antagonists in BMDCs cultures
and antigen-specific in vitro proliferation assays [19]. In addition,
analysis of lung DCs obtained from CCR5
2/2 mice, demonstrat-
ed that they are less efficient capturing FITC-dextran and express
fewer levels of CD86 and MHC Class II molecules compared to
wild type mice [20]. Another chemokine, CCL16, induces an
increase in the expression of CD80 and CD86 molecules on DCs
through a process that involves p38 and PLC signalling [21]. More
interestingly, CCL19 and CCL21 have recently been involved in
DC maturation, by enhancing the up-regulation of CD86 and
CD40 expression markers, whereas CCL19 stimulation also led to
increased secretion of IL-12, IL-1b and TNFa [6] from DCs. In
Figure 7. Reduced T lymphocyte proliferation responses induced by Jak3
2/2 DCs. 1610
5 T lymphocytes from Jak3
+/+ Balb/c AnN mice
were CFSE-labelled and co-cultured with Jak3
+/+ or Jak3
2/2 mBMDCs in RPMI 10% SFB for 5–7 days at different DCs: T cell ratios (1:2, 1:20), as
described in Methods. Cells were harvested from the cultures and stained with anti-CD4 and anti-CD8 antibodies. A) A representative experiment is
shown. B) Negative control for T cell proliferation, in unstimulated CD4
+ or CD8
+ gated subpopulations. C) Data represents the percentage of
proliferation at different cell ratios expressed as mean values 6 SEM (n=6; p#0.05).
doi:10.1371/journal.pone.0007066.g007
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CCL21 induce Jak3 phosphorylation in T lymphocytes [14]. Thus,
a mechanism by which the lack of Jak3 could negatively affect
their maturation might be through a deficiency in the CCR7
signalling pathway. In contrast, expression of costimulation
markers on mature DCs after stimulation with IL-4 appeared to
be independent of Jak3. However, the production of IL-12, p70,
induced by microbial products was shown to require Jak3 [22].
Altogether, these findings suggest that Jak3 might not be directly
involved in the DC development but rather it may regulate their
maturation and effector functions.
A requirement for DC function is their ability to migrate to
peripheral lymph nodes, where they undertake a key role during the
priming of naive T lymphocytes. Migration of mature DCs to LN
occurs through the afferent lymphatics and has been shown to
involve CCR7-mediated signalling [23], as assessed by the
decreased homing of DCs into the lymph nodes observed in
CCR7
2/2 mice[24] or inplt/pltmice[8].Furthermore, CCR7 was
shown to be a key regulator that governs trafficking of skin DCs
under both inflammatory and steady state conditions [5]. Our
group has previously demonstrated that Jak3 is required for CCR7
mediated T lymphocyte homing to peripheral LN [14]. In this
study, we analyzed the role of Jak3 in the migration of mature DCs
both in vitro and in vivo. We found impaired migration of Jak3
2/2
BMDCs towards CCL19 and CCL21. Our in vitro experiments
showed that Jak3
2/2 mature DCs have lower migration towards
CCL19 and CCL21 compared to Jak3
+/+ mature DCs. These data
indicate that the impaired migration of Jak3
2/2 DCs must be due
to CCR7-deficient signalling in the absence of Jak3. More
importantly, in vivo adoptive transfer assays using mature GFP
+-
BMDCs, showed that Jak3
2/2 DCs arrival to LN is reduced in
about 80% compared to Jak3
+/+ DCs. Taken together, these results
may imply an important role of Jak3 in the CCR7-mediated
signalling during the migration of DCs into the lymphatic vessels.
To further assess the relevance of the Jak3 expression in DCs
migration, we developed an ex-vivo model of migration using
whole ear skin cultures. It has been described that chemokines and
other molecules such as CD47[25], prostaglandins [26,27] and
leukotrienes [28] regulate the exit of LC from skin and their later
arrival into the lymph nodes. In the epidermis DCs interact with
keratinocytes through E-cadherin homophilic interactions [29]. It
is known that molecules such as JAM-A are also involved in
retaining DCs at the epidermis [30], whereas ICAM-1 expressed
in the lymphatic endothelium is involved in the entry of LC into
Figure 8. Jak3
2/2 mice show reduced CHS responses. Mice were sensitized in the right ear with 10 ml of 1% DNFB-olive oil and five days after
challenged with the same hapten solution. Frozen sections were obtained at different time points and a Haematoxylin/Eosin staining was performed.
A) H&E staining of ear skin at 0 and 72 h after challenge from a representative experiment is shown. B) Total cell numbers per mm
2 were quantified in
the dermis after challenge. C) The ear thickness from the perichondrium to basal membrane after the challenge was calculated. Data represents the
mean of four independent experiments 6 SEM (n=3). Magnification 406(*p#0.05; **p#0.01).
doi:10.1371/journal.pone.0007066.g008
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that Jak3 might be involved in the development of human
epidermis [32], Jak3
2/2 mice showed no apparent alterations in
the epidermis (Figures 5B and 9B); indeed, these mice displayed
normal numbers of LC compared to Jak
+/+ mice. Furthermore,
our results demonstrated that DCs from Jak3
2/2 mice are fully
capable of leaving the epidermis.
DCs leaving the epidermis into the dermis locate along the
lymphatic vessels of the dermis to form the so-called ‘‘cords’’. The
formation of these structures may be of relevance during the entry
process into these vessels. Interestingly, CCR7
2/2 DCs fail to
form these ‘‘cords’’ within the dermis [5]. Similarly, our data
showed that DCs from the Jak3
2/2 are greatly impaired in their
ability to form these dermal ‘‘cords’’.
In addition, we analysed the ability of DCs to induce T cell
proliferation in the absence of Jak3. We found that allogeneic T
lymphocyte proliferation is significantly reduced after contact with
Jak3
2/2 DCs when a ratio 1:20 (DC: T cell) was used compared
to the proliferation obtained with Jak3
+/+ DCs at the same ratio.
This decreased proliferation might be explained by a defective
expression of costimulatory molecules in the Jak3
2/2 DCs and/or
to decreased DCs cytokine production. When increased ratios of
Jak3
2/2 DC: T cell were used, normal levels of proliferation were
obtained, indicating that increasing the number of DCs can
compensate the difference in the levels of costimulatory molecule
expression. Since only 10% of the total T lymphocyte repertoire
recognizes MHC alloantigens, increasing the number of MHC-
peptide complexes augmented the efficiency of peptide recognition
on the allogeneic DCs. In this context, previous reports from
others and from our laboratory (data not shown) using an OVA
TCR-specific transgenic system, reported no significant differences
in T lymphocyte activation in the absence of Jak3 [15].
Next, to evaluate in vivo DC-mediated functions, CHS assays
using DNFB were performed. A subsequent antigen challenge
induces activation of macrophages and lymphocytes primarily,
leading to inflammation. To reach the lymph nodes, the DCs
should enter the lymphatic vessels. The evidence that Jak3
2/2
DCs were unable to form ‘‘cords’’ around the lymphatic vessels
and that they did not reach the lymph nodes after adoptive
transfer, is consistent with the fact that inflammation in the CHS
responses, measured as the ear thickness obtained after challenge,
was always lower in the skin of Jak3
2/2 mice compared to that of
Jak3
+/+ mice. Interestingly, even though untreated Jak3
2/2 mice
consistently presented thicker ears than Jak3
+/+ mice, ear thickness
did not increase after challenge in the Jak3
2/2 mice. In addition,
although challenge of Jak3
2/2 mice with DNFB induced
significant cell recruitment at the site of inflammation compared
to mice treated with the vehicle, the cell counts were much lower
that those seen in Jak3
+/+ mice. These results correlate with the in
vivo data showing a decrease in the number of migrating DCs
reaching the draining LN, which may result in decreased T cell
activation. In addition, since Jak3
2/2 mice lack peripheral LN, it
is likely that cognate T lymphocyte activation takes place in
another secondary lymphoid organ, such as the spleen. In this
Figure 9. Jak3 has a role in the restoration of LC population at the epidermis. After challenge, epidermis and dermis were separated at
different time points as described in materials and methods. A) The epidermis was stained at 6 and 72 h after challenge using an anti-MHCII antibody
followed by streptavidin-HRP (upper panels). Staining with anti-Langerin and anti-FITC labelled secondary antibody was also performed (lower panel).
B) Cell number was quantified and data represent the mean of three individual assays performed in triplicate (*p#0.05; ** p#0.01).
doi:10.1371/journal.pone.0007066.g009
Jak3 Regulates DC Functions
PLoS ONE | www.plosone.org 9 September 2009 | Volume 4 | Issue 9 | e7066context, in the plt/plt mice, where entry of T lymphocytes and DCs
to the LN is greatly impaired, a proportion of T cell responses are
shifted to the spleen. Interestingly, in these mice responses to
contact sensitization were decreased at day 2 after priming but
increased at day 6, leading to enhanced T cell responses [33].
We also determined the Langerhans cell numbers at the site of
inflammation, after challenge, in the CHS assays. Under steady-
state conditions, LCs leave the skin with a low but constant
frequency. These cells might be maintained by a stable and
renewable precursor population in the skin [5,34,35]. Conversely,
under inflammatory conditions, this subpopulation is replaced by
blood-borne LC progenitors [35,36]. These precursors are Gr1
+
monocytes, which are incorporated into the epidermis where they
become Langerin positive and acquire the morphology charac-
teristic of LCs [36]. In our assays, we found that after antigen
challenge, Jak3
2/2 LCs did not repopulate the epidermis with the
same efficiency that those from Jak3
+/+ mice, which suggests that
this Jak3 kinase might be involved in this process.
Altogether, the deficiencies in maturation and migration
induced through CCR7 in Jak3
2/2 DCs allow us to conclude
that Jak3 is involved in both processes; hence its absence affects
negatively both the DC migration and DC-mediated func-
tions.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the Animal Experimental Bio-Ethics
Guidelines of the Instituto de Investigaciones Biome ´dicas. All
animal work was approved by the Animal Experimental Bio-Ethics
Committee of the Instituto de Investigaciones Biome ´dicas, UNAM.
Mice
C57BL/6, Jak3-deficient mice (Jak3
–/–) (C57BL/6-
JAK3tm11jb) were obtained from The Jackson Laboratories (Bar
Harbour, ME) and Balb/c AnN mice were obtained from the
animal facility at the Instituto de Investigaciones Biome ´dicas
(UNAM, Mexico) and kept in pathogen-free conditions. Actin-
green fluorescent protein (GFP) transgenic mice on the C57BL/6
background were obtained from Dr M. Okawa (Genome
Information Research Center, Osaka University, Japan). These
mice were crossed with Jak3
–/– mice for a few generations in order
to obtain actin-GFP transgenic mice on the Jak3
–/– background.
Six to ten week-old homozygous Jak3
–/–mice were used. In some
experiments C57BL/6 age-matched mice (wild type) were used as
controls.
In vitro differentiation of Bone Marrow derived
Dendritic Cells. BM derived Dendritic cells were
generated and derived as described earlier [37].
Briefly, BM was extracted from the femurs and tibias
of Jak3
+/+ and Jak3
2/2 mice. Red cells were lysed with a
l y s i sb u f f e r( 0 . 8 3 %a m m o nium chloride) and 5610
6 BM
cells were derived after culture in 10% FBS containing
RPMI, supplemented with 15% of supernatant from the
GMCSF stably transfected CHO cell line [38]. After 5
days, cells were analyzed for expression of Class II and
CD11c (iBMDC) by flow cytometry. To induce mature
BMDC (mBMDC), cells were stimulated with 1 mg/ml
LPS (E. coli 0111:B4, Sigma Chemical, St. Louis, MO)
for 24 h and phenotypically assessed by flow cytometry,
as before. BMDCs were identified by gating the
CD11c
+/high Class II
+ subpopulation, as previously
described [39].
Flow Cytometry
Single-cell suspensions from spleen were prepared as previously
described [14]. Cells were stained with PE-labelled anti-CD86, PE-
labelled anti-CD80 and FITC-labelled anti-CD11c (BioLegend, San
Diego, CA), PE-labelled anti-CD11c (Becton Dickinson, San Jose,
CA), biotin-labelled anti I-A/I-E (2G9, Becton Dickinson) followed
by streptavidin-cychrome (Becton Dickinson).T oa s s e s s
CCR7 expression, a CCL19-Ig fusion protein (generously provided
by Dr. U. von Andrian, Harvard University, Boston, MA) was used
as previously described [14], followed by a FITC-labelled goat anti-
hIgG secondary antibody. For biotin-conjugated antibodies,
we used cells stained with streptavidin–cychrome alone
(Becton Dickinson) as a negative control. For directly
conjugated monoclonal antibodies, unstained cells were
used as controls, and staining with an irrelevant mono-
clonal conjugated antibody. Cells were acquired in a FACSCa-
libur flowcytometer(Becton Dickinson) and data wasanalyzed using
Cell Quest Pro software (Becton Dickinson).
In vitro migration of Bone Marrow derived Dendritic Cells
2610
6 BM cells were obtained from Jak3
2/2 or Jak3
+/+ mice,
BMDCs were generated, fluorescently pre-labelled and used in in vitro
migration assays as described before [14]. Fluorescent migrating cells
were quantified using a Molecular Imager (Bio-Rad, Hercules, CA).
In vivo migration of Bone Marrow derived Dendritic Cells
Mature BMDCs (mBMDC) from Jak3
+/+-GFP
+ and Jak3
2/2-
GFP
+ mice were obtained and derived as described above. 1610
6
mBMDC were resuspended in PBS and injected into the right
footpad of Jak3
+/+ recipients. The left footpad was injected with
PBS and used as control. After injection, popliteal lymph node
were extracted at different time points (24, 36, 48 and 72 h),
minced and analyzed by flow cytometry to identify GFP
+ cells.
Skin organ culture
Dorsal and ventral ear halves were obtained and rinsed twice in
70% ethanol, and once with sterile PBS. The ears halves (whole
skin) were cultured in RPMI, 10% SFB. At the indicated time,
pieces were carefully cut and the skin was separated into dermis
and epidermis, to obtain epidermal sheets as described below.
Histological sections were obtained from frozen dermis (at 280uC)
and stained with an anti-mouse Langerin antibody (CD207,
eBioscience, San Diego, CA) and FITC-labelled goat anti-rat IgG
(H+L) antibody to identify LC in the epidermal sheets and to
locate dermal cords in the dermis.
Preparation and staining of epidermal sheets
Epidermal sheets were obtained from ears of Jak3
+/+ and Jak3
2/
2 mice as described [40]. Briefly, mice were sacrificed,
ears were cut off at the base and the skin was separated
into epidermis and dermis by using 20 mM EDTA/PBS
incubation for 10 min at 65uC. The epidermal sheets were
rinsed with PBS, fixed in cold acetone and stained with anti-CD207
antibody and with a biotinylated anti I-A/I-E (2G9) antibody
(Becton Dickinson), followed by streptavidin-HRP (Amersham
Biotech, UK) and DAB (Zymed, Carlsbad, CA). Dermis was
snap frozen and cryostat sections were generated for
further fluorescence microscopical analysis.
Contact Hypersensitivity (CHS) assays
2,4-dinitro-1-fluorobenzene (DNFB) was applied onto the
mouse left ears at the concentration of 1% in acetone-olive oil
(4:1). Five days after sensitization, dorsal ears were challenged with
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measured using an engineer’s micrometer, and compared with ear
thickness prior to challenge. Ear whole skin was obtained, and
epidermal sheets were prepared and stained by immunochemistry
as described above. Dermis sections were obtained as
above, snap frozen and cryostat sections were stained with
haematoxylin and eosin (H&E). Morphometrical analysis was
performed using the Image-Pro Plus 6.0 software (Media
Cybernetics, Inc. Silver Spring, MD) and measuring five fields
from each ear section and contrasting controls against challenged
mice. Results were expressed as cells/mm
2.
Lymphocyte proliferation assays
Single cell suspensions were prepared from spleen and
peripheral LN from Balb/c AnN mice as described above. B
lymphocytes were depleted through panning using an anti-B220
antibody for 1 h at 37uC. 1610
5 T lymphocytes were labelled with
CFSE (Molecular Probes, Eugene, OR) at 37uC, and seeded into
96 well plates. Mature BMDCs were obtained from Jak3
+/+ and
Jak3
2/2 mice and co-cultured with T lymphocytes at different
ratios (T lymphocytes: mBMDCs 1:1, 1:2, 1:4, 1:10 and 1:20).
After 5, 6 and 7 days of co-culture, cells were stained with PE-
labelled anti-CD4 and PE-Cy5-labelled anti-CD8 (Becton Dick-
inson) antibodies and analyzed by Flow Cytometry as described
above. Analysis was performed on CD4 or CD8 gated subpop-
ulations. To calculate percentage of proliferation, a gate was set
using unstimulated cells.
Statistical analysis. Unpaired two-tailed Student T-test was
performed for the analysis of statistical significance; p,0.05 was
considered as significant.
Supporting Information
Figure S1 Expression of costimulatory molecules in freshly
isolated DCs from Jak 32/2 mice. FACS analysis from spleen
DCs from Jak3+/+ and Jak32/2 stained with anti-CD80 and
anti-CD86 antibodies. Graphs represent Mean Fluorescence
Intensity (MFI) of cells expressing CD80 (left) and CD86 (right),
gated on CD11c+ MHCII+. Mean values 6SEM are shown
(n=11) (*p=0.04; NS=non-significant).
Found at: doi:10.1371/journal.pone.0007066.s001 (0.22 MB TIF)
Figure S2 Schematic representation of LC migration under
homeostatic (A) or inflammatory (B) conditions. A) Homeostatic
Conditions: LC exit slowly from epidermis in a multistep process
that may take several days. 1). Molecules such as JAM-A [30] and
others, such as Jak3, mediate retention of Dendritic Cells in
epidermis. Under homeostatic conditions, LC leave the epidermis
towards the dermis in a process independent of CCR7. 2). LC
enter into the lymph vessels to initiate migration to lymph nodes.
This process involves participation of molecules such as CD47 [25]
and CCR7-CCL21. LC precursors present in the dermis are
responsible to repopulate lymph node under steady state
conditions [34]. B) Inflammatory state: LCs leave the epidermis
in a coordinated process that includes several steps. 1). After
sensing or capture of antigen, LCs leave the epidermis by a CCR7-
independent mechanism. In this work we find that similar to this,
the LCs do not need Jak3 to leave the epidermis. 2). To get entry
into the lymphatic vessels and arrival to LNs, it has been
demonstrated that LCs are dependent of CCR7 and other
molecules as LT4 [42], MMP [43] and CXCR4 [44]. Jak3 may
also be involved in this process. 3). CCR2+ GR1+ blood
precursors are important to restore the LC population after
inflammation. Chemokine-mediated signalling through the Jak-
Stat pathway, and in particular Jak3 may also be important, as it is
demonstrated in the present report
Found at: doi:10.1371/journal.pone.0007066.s002 (1.40 MB TIF)
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